Theravance Biopharma Inc - Company Profile
Powered by 
All the data and insights you need on Theravance Biopharma Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Theravance Biopharma Inc Strategy Report
- Understand Theravance Biopharma Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Theravance Biopharma Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 13 Jul 2022 | Theravance Biopharma to Sell 85% Stake in Theravance Respiratory to Royalty Pharma | Acquisition |
Royalty Pharma Plc
|
Theravance Respiratory Co LLC
|
| 24 Jun 2021 | Theravance Biopharma Prices Public Offering of Shares for USD100.5 Million | Equity Offering | - |
Theravance Biopharma Inc |
| 02 Mar 2020 | Theravance Biopharma Raises USD400 Million in Private Placement of 9.5% Notes Due 2035 | Debt Offering | - |
Theravance Biopharma Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer